Research Published October 25 2019
Open / close summary

Institut du Cerveau – ICM – Institut du Cerveau et de la Moelle épinière (Brain and Spine Institute) – is an internationally renowned Neuroscience research institute located in Paris, France, on the campus of the Pitié-Salpêtrière hospital, providing world class expertise in basic and clinical neuroscience.

Institut du Cerveau – ICM is seeking to recruit a group leader in the field of in silico biomarker analysis in Alzheimer’s disease (AD) and related dementias. The successful candidate will work in close interaction with Institut du Cerveau – ICM scientists and clinicians of the “Institute for Memory and Alzheimer Disease” (IM2A) at the Pitié-Salpêtrière Hospital.

We welcome applications from early to mid-career investigators with a strong scientific track record in translational research. We are particularly interested in candidates whose research may concern biomarkers of AD and related dementias, multimodal data integration, or in silico disease modeling.

The successful candidate will benefit from a competitive start-up package, including the permanent AXA-Chair and a funding from Merck-Avenir Foundation, both dedicated to biomarkers of Alzheimer, space and recurrent core funding. Candidates will work in a stimulating and collaborative international environment with a facilitated access to well-structured cohorts in the field of neurodegenerative diseases. Group leaders at the Institut du Cerveau – ICM are affiliated with the Neuroscience Ph.D. program of the Sorbonne Université. Skilled assistance for applications to national and international funding programs will be also provided (e.g. ERC, CNRS, Inserm, ANR, ATIP-Avenir, Equipes FRM).

Institut du Cerveau – ICM is home to 25 research teams bringing together more than 700 personnel, including 150 researchers, 200 technical staff and 300 students and post-docs. Institut du Cerveau – ICM laboratories use multiscale approaches from cellular and molecular neurobiology, neurophysiology, systems to cognitive neuroscience. Institut du Cerveau – ICM offers state-of the-art core facilities that support fundamental, preclinical and clinical research, including access to human tissue.

Institut du Cerveau – ICM is a private foundation working in synergy with French public bodies, and affiliated with Sorbonne Université, CNRS and INSERM. Importantly, Institut du Cerveau – ICM is associated with the Medical University Department (DMU) for the Diseases of the Nervous System of the Pitié-Salpêtrière hospital (APHP), as well as with a large network of public and industrial partners. Institut du Cerveau – ICM is dedicated to fundamental, translational and clinical research in Neuroscience, and fosters improved quality of care and education. Moreover, it hosts an in-house neuroscience clinical research center, spinoff, start-ups companies. Institut du Cerveau – ICM is located alongside 13 National Reference Centers at the Pitié-Salpêtrière for rare neurological diseases.

Expression of interest must include a 2-page CV, a complete list of publications highlighting up to five of the most significant papers, a brief description of achievements and future research (2 pages). Applications must be sent by January 15th 2020 to Dr. Alexandra Auffret at the following address:

Short-listed applicants will be requested to send the full application proposal (attached file) including :

– Project title and summary and a list of up to five of the candidate’s most significant publications (limited 2 pages)

– Full CV including list of publications and invited presentations to conferences

– Description of the research project (no more than 10 pages)

– Names and contacts of at least three referees

Full applications must be sent by April 30th 2020 at the following address All applications will be reviewed by members of the Scientific Advisory Board of the institute and international experts in the field. Short-listed applicants will be invited for an interview and oral presentation in Paris in June 2020.